The Uromigos Episode 180: Enzalutamide Versus Active Surveillance in Early Prostate Cancer

By The Uromigos - Last Updated: June 20, 2022

Neal Shore describes his recent controversial paper on enzalutamide versus active surveillance in early prostate cancer. He has a keen interest in examining the over-diagnosis and over-treatment of patients with low-grade disease, particularly in patients and providers who become uncomfortable in maintaining fidelity to active surveillance.

Post Tags:Uromigos-Prostate Cancer
Advertisement
Advertisement